USD 59.33
(2.17%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 260.87 Million USD | 8.49% |
2023 | 240.45 Million USD | 26.41% |
2022 | 190.22 Million USD | 55.42% |
2021 | 122.39 Million USD | 54.3% |
2020 | 79.32 Million USD | 16.85% |
2019 | 67.88 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 FY | 252.93 Million USD | 5.19% |
2024 Q4 | 63.63 Million USD | -1.4% |
2024 Q2 | 59.12 Million USD | -9.92% |
2024 Q3 | 64.54 Million USD | 9.16% |
2024 Q1 | 65.63 Million USD | 1.84% |
2023 Q3 | 63.25 Million USD | 11.21% |
2023 FY | 240.45 Million USD | 26.41% |
2023 Q4 | 64.44 Million USD | 1.89% |
2023 Q2 | 56.87 Million USD | 1.78% |
2023 Q1 | 55.88 Million USD | 3.54% |
2022 Q3 | 51 Million USD | 12.22% |
2022 Q4 | 53.96 Million USD | 5.81% |
2022 Q1 | 39.8 Million USD | 11.05% |
2022 FY | 190.22 Million USD | 55.42% |
2022 Q2 | 45.44 Million USD | 14.17% |
2021 Q4 | 35.84 Million USD | 8.95% |
2021 FY | 122.39 Million USD | 54.3% |
2021 Q1 | 26.43 Million USD | 18.96% |
2021 Q3 | 32.9 Million USD | 20.87% |
2021 Q2 | 27.22 Million USD | 2.99% |
2020 Q3 | 21.26 Million USD | 0.0% |
2020 Q4 | 22.21 Million USD | 4.48% |
2020 FY | 79.32 Million USD | 16.85% |
2019 FY | 67.88 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Well Corporation | 786.9 Million USD | 66.848% |
Evolent Health, Inc. | 531.68 Million USD | 50.934% |
MultiPlan Corporation | 564.07 Million USD | 53.752% |
Phreesia, Inc. | 369.84 Million USD | 29.463% |
Teladoc Health, Inc. | 2.09 Billion USD | 87.524% |
Veeva Systems Inc. | 1.25 Billion USD | 79.247% |